logo

Oramed Pharmaceuticals Inc. (ORMP)



Trade ORMP now with
  Date
  Headline
11/23/2021 8:27:39 AM Oramed Reaches 75% Enrollment In Phase 3 Oral Insulin Study On Type 2 Diabetes
11/18/2021 7:45:37 AM Oramed Subsidiary Oravax Medical And Genomma Form JV To Develop And Commercialize Oral COVID-19 Vaccine In Mexico
10/29/2021 7:29:01 AM Oramed Says Oravax's Oral COVID-19 Vaccine Gets South African Approval To Begin Phase 1 Trial
9/15/2021 8:12:41 AM Oramed Says Phase 2 Oral Insulin Non-alcoholic Steatohepatitis Trial Reaches Over 50% Enrollment
8/24/2021 8:30:49 AM Oramed Enrolls Over 25% In Its Second Of Two Concurrent Phase 3 Oral Insulin Trials
8/16/2021 8:35:44 AM Oramed Announces Publication Of Oral Insulin Study In Peer-Reviewed Journal
8/5/2021 6:50:57 AM Oravax To Present Keynote Talk On Oral COVID-19 Vaccine
7/21/2021 8:27:59 AM Oravax Signs Deal For Virus-like Particle Injectable Vaccine Tech With Premas Biotech For Commercialization In India
6/8/2021 8:13:29 AM Oramed Enrolls Over 50% In Phase 3 Oral Insulin Study
5/25/2021 8:44:34 AM Oramed Says Phase 3 Studies Of Oral Insulin Underway And On Schedule
3/23/2021 9:10:24 AM Oramed Initiates Second Phase 3 Oral Insulin Study For Type 2 Diabetes
3/19/2021 8:48:20 AM Oramed To Form JV, Oravax Medical, To Develop Oral COVID-19 Vaccines; Stock Up
1/21/2021 8:36:49 AM Oramed Says Doses Patients Across Multiple Sites In Phase 3 Oral Insulin Study